1986
DOI: 10.1016/s0022-3476(86)81017-4
|View full text |Cite
|
Sign up to set email alerts
|

Intestinal perforations after enteral administration of indomethacin in premature infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

1999
1999
2016
2016

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 3 publications
0
6
0
Order By: Relevance
“…Indomethacin reduces renal artery blood flow velocity shortly after administration in preterm infants [1]. Indomethacin is associated with an increased incidence of intestinal bleeding and perforations in the preterm infant [41][42][43][44][45]. Coombs et al [2] and Van Bel et al [3] noted a significant reduction in superior mesenteric artery blood flow velocity in preterm infants receiving indomethacin.…”
Section: Discussionmentioning
confidence: 99%
“…Indomethacin reduces renal artery blood flow velocity shortly after administration in preterm infants [1]. Indomethacin is associated with an increased incidence of intestinal bleeding and perforations in the preterm infant [41][42][43][44][45]. Coombs et al [2] and Van Bel et al [3] noted a significant reduction in superior mesenteric artery blood flow velocity in preterm infants receiving indomethacin.…”
Section: Discussionmentioning
confidence: 99%
“…60,61 Enteral administration is the most studied alternative to the IV formulation. In 1979, Cooke 62 reported an inadequate response to oral indomethacin provided at 0.2 mg/kg/dose every 12 hours for 3 doses; 5 of the 7 treated infants had no clinical response.…”
Section: Treatment Of Hspdamentioning
confidence: 99%
“…The investigators speculated that perhaps their findings were related to a locally induced prostaglandin deficiency resulting in less cytoprotection in the gastrointestinal tract. Kuhl and Sey-berth 60 hypothesized that the gastrointestinal side effects are not a local effect caused by oral administration, but rather decreased gut perfusion caused by the PDA, coupled with the blockage of mucosal vasodilation and integrity normally provided by prostaglandins. Similar findings were reported in a single case report in a letter to the editor in 1985 and by Nagaraj 61 in 1981 in which 8 of 82 infants given enteral indomethacin developed a focal perforation in various locations in the gastrointestinal tract.…”
Section: Treatment Of Hspdamentioning
confidence: 99%
“…[6][7][8][9][10] Although it can be difficult to distinguish SIP from necrotizing enterocolitis (NEC) based on clinical presentation, the distinct histopathology [11][12][13][14] of an isolated or focal perforation makes SIP recognizable as a disease process separate from NEC. Widespread recognition of SIP began in the 1980's following the advent of indomethacin therapy for patent ductus arteriosus closure, [15][16][17][18] but the exact etiology remains unknown to date. Well-known risk factors for SIP include extreme prematurity and the concurrent use of steroids and indomethacin in the early postnatal period.…”
Section: Introductionmentioning
confidence: 99%